Jan 03, 2019 9:00am EST Avalon GloboCare Establishes Joint Venture with Arbele Limited to Co-develop Next-Generation Multi-Targeted CAR-T Cellular Immunotherapy
Dec 19, 2018 8:00am EST Avalon GloboCare to Ring the Nasdaq Stock Market Closing Bell on January 7, 2019 at 4:00 PM Eastern
Nov 13, 2018 9:05am EST Avalon GloboCare Provides Third Quarter 2018 Business Update; Reports 30% Increase in Revenues
Oct 15, 2018 8:00am EDT Avalon GloboCare Announces Grand Opening of Newly Renovated Headquarters in New Jersey
Oct 09, 2018 9:00am EDT Avalon GloboCare Teams Up with Weill Cornell Medicine to Co-develop Standardization of cGMP-Grade Exosome Isolation and Application of Tissue-Specific Exosomes
Sep 20, 2018 8:00am EDT Avalon GloboCare Commences Operation of its Core GMP Platform, Epicon Biotech, to Facilitate Clinical Development of Cellular Therapies
Aug 15, 2018 8:00am EDT Avalon GloboCare Provides Second Quarter 2018 Business Update; Reports 32% Increase in Revenues
Aug 14, 2018 7:30am EDT Avalon GloboCare Appoints Dr. James L. Gajewski, Former Medical Director at M.D. Anderson Cancer Center, to Head Scientific and Clinical Advisory Board
Aug 07, 2018 7:30am EDT Avalon GloboCare Forms Strategic Partnership with Weill Cornell Medical College to Co-develop Technologies and Bio-production of CAR-T Therapy